Skin cancer – Basal cell carcinoma

Published on 04/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 926 times

Skin cancer – Basal cell carcinoma

Malignant skin tumours are among the most common of all cancers. They are more frequent in light-skinned races, and ultraviolet (UV) radiation seems to be involved in their aetiology. The incidence of non-melanoma skin cancer in caucasoids in the USA was recently estimated at 230 per 100 000 per year, compared with 3 per 100 000 for African Americans. The majority of malignant skin tumours (Table 1) are epidermal in origin and are either basal cell or squamous cell carcinomas (p. 100) or malignant melanomas (p. 103). Premalignant epidermal conditions are common (p. 98), but dermal malignancies are comparatively rare.

Table 1 A classification of malignant skin tumours and premalignant conditions

Cell origin Premalignant condition Malignant tumour
Keratinocyte Actinic keratosis (p. 119), in situ squamous cell carcinoma (p. 100) Basal cell carcinoma
Squamous cell carcinoma
Melanocyte Dysplastic naevus (p. 103) Malignant melanoma (p. 103)
Fibroblast   Dermatofibrosarcoma (p. 98)
Lymphocyte   Lymphoma (p. 98)
Endothelium   Kaposi’s sarcoma (p. 56)
Non-cutaneous   Secondary (p. 43)

Clinical presentation

Basal cell carcinomas occur mainly on light-exposed sites, commonly around the nose, the inner canthus of the eyelids and the temple. They grow slowly but relentlessly, are locally invasive and may destroy cartilage, bone and soft tissue structures. A lesion has often been present for 2 years or more before the patient seeks advice. Often more than one tumour is evident. There are four main types of basal cell carcinoma, all of which may occasionally be pigmented:

Differential diagnosis

The differential diagnosis depends on the type, pigmentation and location of the basal cell carcinoma:

image Nodular/cystic: intradermal naevus (p. 96), molluscum contagiosum (p. 53), keratoacanthoma (p. 100), squamous cell carcinoma, sebaceous hyperplasia (a benign proliferation of sebaceous glands).

image Multicentric: discoid eczema (p. 38), psoriatic plaque (p. 29), in situ squamous cell carcinoma (p. 100).

image Morphoeic: morphoea (p. 81), scar.

image Pigmented: malignant melanoma (p. 103), seborrhoeic wart (p. 94), compound naevus (p. 96).

Management

The most appropriate treatment for any one tumour depends on its size, site, type and the patient’s age. If possible, complete excision is the best treatment, as this allows a histological check on the adequacy of removal. If excision is difficult or not possible, incisional biopsy (to confirm the diagnosis) and radiotherapy are suitable for those aged 60 years and over. Large tumours around the eye (Fig. 6) and the nasolabial fold, especially if of the morphoeic type, are best managed by surgical excision. Mohs’ micrographic surgery (p. 112) may be employed, as the margins of these tumours are often difficult to determine and may be extensive. Curettage and cautery is sometimes used for lesions on the trunk or upper extremities. Cryosurgery or topical imiquimod (p. 115) are acceptable modalities for multiple, superficial lesions, e.g. on the trunk.

The recurrence rate is about 5% at 5 years for most methods of treatment. Follow-up is particularly important if there is concern about the adequacy of treatment.